Solís, Leire
Nordin, Julia
Prevot, Johan
Mahlaoui, Nizar
Sánchez-Ramón, Silvia
Ali, Adli
Cassignol, Elodie
Seymour, John W.
Pergent, Martine http://orcid.org/0000-0003-1032-6584
Article History
Received: 17 September 2021
Accepted: 19 December 2021
First Online: 8 January 2022
Declarations
:
: Not applicable.
: Not applicable.
: LS, JN, JP work for and MP, JS are Board members of IPOPI. IPOPI has previously received an unrestricted grant from Shire (now Takeda) to support the development of the PID Life Index. IPOPI has also previously received unrestricted grants from Takeda and support from a broad range of companies involved in the field of primary immunodeficiencies outside the scope of the PID Life Index development. For an updated list of IPOPI’s corporate partners please visit ExternalRef removed. EC works for Quadrature du Cercle, the agency that received funding from IPOPI for the technical development of the PID Life Index.